Fascin-1 and its role as a serological marker in prostate cancer: a prospective case–control study
| Autor: | Octavian Sabin Tătaru, Orsolya Martha, Felice Crocetto, Biagio Barone, Septimiu Voidazan, Angela Borda, Anca Sin, Adina Hutanu, Andrada Loghin, Ileana Sin, Daniel Porav-Hodade, Calin Bogdan Chibelean, Liliana Vartolomei, Giuseppe Lucarelli, Matteo Ferro, Virgil Gheorghe Osan, Carlo Buonerba, Mihai Dorin Vartolomei |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: | |
| Zdroj: | Future Science OA, Vol 7, Iss 9 (2021) |
| Druh dokumentu: | article |
| ISSN: | 2021-0051 2056-5623 |
| DOI: | 10.2144/fsoa-2021-0051 |
| Popis: | Aim: This study aims to investigate any modification of serological FSCN1 in prostate cancer patients compared with patients without neoplasia. Material & methods: Clinical data and blood specimens from patients with and without prostate cancer were obtained. A quantitative sandwich ELISA method was used to determine serological values of FSCN1. Results: Although serum values of FSCN1 were dissimilar in the two cohorts of patients (6.90 vs 7.33 ng/ml), the difference was not statistically significant (p = 0.20). Serum values of FSCN1 stratified for Gleason score groups were not significantly distinguishable (p = 0.65). A negative correlation (rho = -0.331; p = 0.009) was reported between FSCN1 and age. Conclusion: Further studies are required to evaluate a possible diagnostic role of FSCN1 in prostate cancer. |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|